[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Pages 23964-23965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09133]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0042]
Healthcare Infection Control Practices Advisory Committee
(HICPAC); Notice of Meeting and Request for Comment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by audio phone lines available. The public is
welcome to listen to the meeting by teleconference at 1-800-369-1817,
and the passcode is 5200122; 200 teleconference lines are available.
Registration is required. Interested parties may register at https://www.cdc.gov/hicpac.
DATES: The meeting will be held on June 4, 2020, 9:00 a.m. to 3:00
p.m., EDT.
Written comments must be received on or before May 21, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0042 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Koo-Whang Chung, M.P.H., Centers for Disease Control
and Prevention, l600 Clifton Road, NE, MS H16-3, Atlanta, Georgia
30329-4027, Attn: HICPAC meeting.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written comments received in advance of the meeting will be included in
the official record of the meeting.
Meeting information: The teleconference access is 1-800-369-1817,
and the passcode is 5200122.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, MS H16-3, Atlanta, Georgia 30329-4027; Telephone: 404-639-
4000; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where
[[Page 23965]]
healthcare is provided; and (3) periodic updating of CDC guidelines and
other policy statements regarding prevention of healthcare-associated
infections and healthcare-related conditions.
Public Participation
Procedure for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Written Public Comment: The public is welcome to submit written
comments in advance of the meeting. Comments should be submitted on or
before May 21, 2020. All requests must contain the name, and
organizational affiliation of the speaker, as well as the topic being
addressed. Written comments should not exceed one single-spaced typed
page in length. Written comments received in advance of the meeting
will be included in the official record of the meeting. Comments
received, including attachments and other supporting materials, are
part of the public record and are subject to public disclosure.
Comments will be posted on https://www.regulations.gov. Therefore, do
not include any information in your comment or supporting materials
that you consider confidential or inappropriate for public disclosure.
If you include your name, contact information, or other information
that identifies you in the body of your comments, that information will
be on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted to
the docket.
Matters To Be Considered: The agenda will include updates from the
following HICPAC workgroups: The Healthcare Personnel Guideline
Workgroup; the Long-term Care/Post-acute Care Workgroup; the National
Healthcare Safety Network Workgroup; and the Bloodstream Infection
Guideline Workgroup. Agenda items are subject to change as priorities
dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Dated: April 24, 2020.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-09133 Filed 4-29-20; 8:45 am]
BILLING CODE 4163-18-P